PhuturdexDrug Pipeline Intelligence

Phuturdex › Drugs › Olomorasib

Drugs in development · updated 30 October 2026

Olomorasib: clinical trials and development status

Other names and codes: LY3537982

FDA substance registryNot approved in the USNo EMA authorisationEstimated launch Jan 2029 – Nov 2029 (Phuturdex estimate)

As of 30 October 2026 Olomorasib is in 6 active clinical trials (recruiting or ongoing, phases I–III) for 16 diseases. The most advanced phase is III.

6Active trials
IIIMost advanced phase
16Diseases studied

Summary updated every week · data as of 30 October 2026. In Phuturdex you can follow Olomorasib and get an email at every change or safety alert.

Sign in free →

Diseases studied

For each disease: the drug’s most advanced phase and active trials, with the reference trial on ClinicalTrials.gov.

DiseaseMost advanced phaseActive trialsReference trial
Non-small-cell lung carcinomaIII5NCT06119581
Bronchial neoplasmIII1NCT06119581
Carcinoma, BronchogenicIII1NCT06119581
Lung diseaseIII1NCT06119581
Lung neoplasmIII1NCT06119581
MetastasisIII1NCT06119581
NeoplasmIII1NCT06119581
Neoplastic ProcessesIII1NCT06119581
Respiratory diseaseIII1NCT06119581
Respiratory tract neoplasmIII1NCT06119581
Thoracic NeoplasmsIII1NCT06119581
Colorectal neoplasmII2NCT07814417
Biliary tract neoplasmI–II1NCT04956640
Endometrial neoplasmI–II1NCT04956640
Ovarian neoplasmI–II1NCT04956640
Pancreatic neoplasmI–II1NCT04956640

Everything on Olomorasib

In Phuturdex you get every trial with sponsors, countries and dates, development events, FDA and EMA approvals, patents and exclusivities, orphan designations and safety alerts, with PDF and Excel export. Free until 31 March 2027.

Open in Phuturdex →

Source: Phuturdex analysis of ClinicalTrials.gov (U.S. National Library of Medicine), FDA and EMA data, updated 30 October 2026. Active trials = recruiting or ongoing, phases I–III. Diseases are those named by each trial (NLM MeSH terms). The estimated launch, when shown, is a Phuturdex calculation described on the Method page, not official data.

ItalianoFrançaisDeutsch